PharmaEngine Return On Asset vs. Shares Outstanding
| 4162 Stock | TWD 88.80 1.40 1.55% |
For PharmaEngine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PharmaEngine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PharmaEngine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PharmaEngine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PharmaEngine over time as well as its relative position and ranking within its peers.
PharmaEngine |
PharmaEngine Shares Outstanding vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining PharmaEngine's current stock value. Our valuation model uses many indicators to compare PharmaEngine value to that of its competitors to determine the firm's financial worth. PharmaEngine is number one stock in return on asset category among its peers. It also is number one stock in shares outstanding category among its peers creating about 2,439,490,662 of Shares Outstanding per Return On Asset. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PharmaEngine's earnings, one of the primary drivers of an investment's value.PharmaEngine Shares Outstanding vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
PharmaEngine |
| = | 0.0589 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
PharmaEngine |
| = | 143.69 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
PharmaEngine Shares Outstanding Comparison
PharmaEngine is currently under evaluation in shares outstanding category among its peers.
PharmaEngine Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on PharmaEngine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PharmaEngine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PharmaEngine's important profitability drivers and their relationship over time.
Use PharmaEngine in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PharmaEngine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaEngine will appreciate offsetting losses from the drop in the long position's value.PharmaEngine Pair Trading
PharmaEngine Pair Trading Analysis
The ability to find closely correlated positions to PharmaEngine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PharmaEngine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PharmaEngine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PharmaEngine to buy it.
The correlation of PharmaEngine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PharmaEngine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PharmaEngine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PharmaEngine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your PharmaEngine position
In addition to having PharmaEngine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investment Grade ETFs Thematic Idea Now
Investment Grade ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Investment Grade ETFs theme has 263 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investment Grade ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for PharmaEngine Stock Analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.